(Q47927959)

6 February 2018

title

Nephrogenic fibrosing dermopathy: response to high-dose intravenous immunoglobulin. (English)

1 reference

6 February 2018

author name string

Chung HJ

series ordinal

1

1 reference

6 February 2018

Chung KY

series ordinal

2

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 March 2004

1 reference

6 February 2018

British Journal of Dermatology

published in

1 reference

6 February 2018

volume

150

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

596-597

1 reference

6 February 2018

Nephrogenic fibrosing dermopathy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05795.X

Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05795.X

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05795.X

Scleromyxedema-like fibromucinosis in a patient undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05795.X

Intravenous immunoglobulins control scleromyxoedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05795.X

High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2003.05795.X

10.1111/J.1365-2133.2003.05795.X

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

release_52hb63baizgjjg6j66wz7s5tb4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/52hb63baizgjjg6j66wz7s5tb4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15030351

1 reference

6 February 2018